Asset-centric life sciences VC spun out of Index Ventures, building and backing companies focused on single high-conviction drug assets with significant ownership positions from seed through late-stage clinical development.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.